Meta-analysis of 10 studies indicate an average TTD of 3.5 years across all dementia types, with younger age at onset and frontotemporal dementia associated with longer diagnostic intervals.

Critics of most-favored-nation drug pricing have warned that it could reduce patient access to certain drugs, raise the prices of other drugs, and decrease research and development for new drugs.

The Food and Drug Administration (FDA) is requiring class-wide label changes for opioid medications to provide additional information on the risks associated with long-term use.

A 58-year-old man presents for a routine annual physical. During the exam, he mentions an intermittent sensation like a “rush of anxiety” that begins in the abdomen and chest and radiates to the head.

Pegcetacoplan inhibits C3 activation by binding to C3 and its activation fragment C3b, thereby reducing C3 glomerular fragment deposition in patients with C3G and primary IC-MPGN.

These findings may partially reflect both structural barriers that delay timely diagnosis and the impact of local equity-driven initiatives that broaden colorectal cancer screening access.

NACT use is associated with superior short- and long-term outcomes for patients with advanced ovarian cancer treated at centers with a higher surgical volume, data suggest.

In analysis of 5268 women from the first childbirth, the proportion of treated women began to decline 18 months before childbirth.

Researchers found that an increased risk of long COVID was seen with financial hardship, food insecurity, less than a college education, and lack of social support.

The FDA has approved the SetPoint System, a neuroimmune modulation device, for the treatment of adults with moderately to severely active rheumatoid arthritis.

Women aged 40 years and older with a first record for any fracture were matched at the fracture index date with up to 5 female controls with no fracture history.